in a randomised , double-blind comparative study involving a total of 1,630 out-patients , tenoxicam ( a new non-steroidal anti-inflammatory drug belonging to the oxicam group ) , piroxicam and diclofenac retard were tested for their efficacy and tolerability in the treatment of osteoarthritis ( oa ) and extra-articular rheumatism ( ear ) .
C0031990
piroxicam
C0029408
osteoarthritis